SEC Form 4 · accession 0001144204-17-028879
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Preti
Other
Period of report
May 18, 2017
Accepted (ET)
May 22, 2017 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2017 | F | 8,842 | $5.13 | D | 33,786 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The reporting person resigned from his position as a director and executive officer effective March 16, 2017, as a result the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of Caladrius Biosciences, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.